Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma.

@article{Chan2000NeoadjuvantAA,
  title={Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma.},
  author={Edwin Chan and Pierce K. H. Chow and B Tai and David Machin and K C Soo},
  journal={The Cochrane database of systematic reviews},
  year={2000},
  volume={2},
  pages={CD001199}
}
OBJECTIVES To determine the efficacy and adverse effects of different neoadjuvant and adjuvant therapies compared to surgery alone or surgery and placebo/supportive therapy when given to improve relapse and survival rates for operable hepatocellular carcinoma. SEARCH STRATEGY Electronic databases, conference proceedings, bibliographies of identified publications. SELECTION CRITERIA All truly randomised and quasi-randomised clinical trials that compared hepatocellular carcinoma patients who… CONTINUE READING